美托洛尔联合稳心颗粒治疗高血压心脏病室性早搏的疗效 闵丽丽 徐慧.docVIP

精品论文 参考文献 美托洛尔联合稳心颗粒治疗高血压心脏病室性早搏的疗效 闵丽丽 徐慧 杭州市下城区天水武林街道社区卫生服务中心康复科 摘要：目的：探究对高血压心脏病室性早搏患者应用美托洛尔联合稳心颗粒方案治疗的临床效果及安全性。方法：随机抽取本院近年来收治高血压心脏病室性早搏患者72例，根据治疗方案差异将其分为对照组与观察组，对照组患者治疗方案为单纯应用美托洛尔，观察组患者在对照组治疗基础上联合稳心颗粒，每组各有患者36例。对比2组患者临床疗效及不良反应事件发生概率。结果：治疗结束后，观察组临床总有效率为83.33%（30/36），相比对照组的61.11%（22/36）更具优越性，差异统计学意义（P＜0.05）；施治前，两组的各项临床指标值基本接近，不具统计学意义（P＞0.05），施治后各项临床指标值均出现变化，且观察组的平均值相比对照组改善更明显，有统计学意义（P＜0.05）；在治疗安全性上，两组施治期间均有不良症状出现，但发生率对比不具统计学意义（P＞0.05）。结论：对高血压心脏病室性早搏患者应用美托洛尔联合稳心颗粒方案治疗，不但临床疗效令人满意且相对于单纯应用美托洛尔治疗，两者联合可降低不良反应事件出现率，具有安全高效的优点，值得临床普及推广。 关键词：美托洛尔；稳心颗粒；高血压心脏病室性早搏 Abstract：Objective：To explore the clinical effect and safety in the treatment of patients with hypertensiveof metoprolol combined with Wenxin particle scheme.Methods：randomly selected in our hospital in recent years treated patients with hypertensive ventricular premature beat in 72 cases，according to the difference of treatment scheme will be divided into control group and observation group，the patients of control group therapy for the simple application of metoprolol，the observation group in the control group patients based on combined with Wenxin granules，36 patients each group.The 2 groups were compared the clinical efficacy and adverse reactions of event probability.Results：after the treatment，the observation group，the clinical total effective rate was 83.33%（30/36），compared with 61.11% in the control group（22/36）has more advantages，statistically significant difference（P lt; 0.05）；before the treatment，the clinical indexes of two groups of values are basically similar，not statistically significant（P gt; 0.05），treatment all clinical index values were changed，and the average value of the observation group compared with the control group improved more significantly，with statistical significance（P lt; 0.05）；in the treatment of the security，have adverse symptoms occurred during the treatment of two groups，but the incidence of contrast with no statistical significance（P gt; 0.05）.Conclusion：the patients with hyperte